Cargando…
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial
INTRODUCTION: Interstitial lung diseases are characterised by scarring of lung tissue that leads to reduced transfer of oxygen into the blood, decreased exercise capacity and premature death. Ambulatory oxygen therapy may be used to treat exertional oxyhaemoglobin desaturation, but there is little e...
Autores principales: | Holland, Anne E, Corte, Tamera, Chambers, Daniel C, Palmer, Andrew J, Ekström, Magnus Per, Glaspole, Ian, Goh, Nicole S L, Hepworth, Graham, Khor, Yet H, Hoffman, Mariana, Vlahos, Ross, Sköld, Magnus, Dowman, Leona, Troy, Lauren K, Prasad, Jyotika D, Walsh, James, McDonald, Christine F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737108/ https://www.ncbi.nlm.nih.gov/pubmed/33318119 http://dx.doi.org/10.1136/bmjopen-2020-040798 |
Ejemplares similares
-
Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease
por: Ekström, Magnus, et al.
Publicado: (2019) -
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
por: Sundh, Josefin, et al.
Publicado: (2019) -
Hospitalised COVID-19 outcomes are predicted by hypoxaemia and pneumonia phenotype irrespective of the timing of their emergence
por: Salter, Brittany, et al.
Publicado: (2022) -
Prevalence and phenotypic trajectories of hypoxaemia among hospitalised adults in Kenya: a single-centre, prospective cohort study
por: Navuluri, Neelima, et al.
Publicado: (2023) -
Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
por: Sundh, Josefin, et al.
Publicado: (2017)